NasdaqGM - Nasdaq Real Time Price USD

Carisma Therapeutics, Inc. (CARM)

1.4413 -0.0187 (-1.28%)
As of 1:25 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
15,073.0000
14,919.0000
9,834.0000
--
--
Operating Expense
100,342.0000
103,650.0000
65,996.0000
40,794.0000
28,378.0000
Operating Income
-85,269.0000
-88,731.0000
-56,162.0000
-40,794.0000
-28,378.0000
Net Non Operating Interest Income Expense
3,945.0000
1,936.0000
-3,145.0000
10.0000
29.0000
Other Income Expense
--
-84.0000
-1,919.0000
--
--
Pretax Income
-81,324.0000
-86,879.0000
-61,226.0000
-40,784.0000
-28,349.0000
Net Income Common Stockholders
-81,215.0000
-86,879.0000
-61,226.0000
-40,784.0000
-28,349.0000
Diluted NI Available to Com Stockholders
-81,215.0000
-86,879.0000
-61,226.0000
-40,784.0000
-28,349.0000
Basic EPS
-1.12
-2.59
-1.52
-1.01
-0.70
Diluted EPS
-1.12
-2.59
-1.52
-1.01
-0.70
Basic Average Shares
40,562.9320
33,524.1970
40,254.6660
40,254.6660
40,254.6660
Diluted Average Shares
40,562.9320
33,524.1970
40,254.6660
40,254.6660
40,254.6660
Total Operating Income as Reported
-85,269.0000
-88,731.0000
-56,162.0000
-40,794.0000
-28,378.0000
Total Expenses
100,342.0000
103,650.0000
65,996.0000
40,794.0000
28,378.0000
Net Income from Continuing & Discontinued Operation
-81,215.0000
-86,879.0000
-61,226.0000
-40,784.0000
-28,349.0000
Normalized Income
-81,215.0000
-86,795.0000
-59,307.0000
-40,784.0000
-28,349.0000
Interest Income
--
1,936.0000
--
10.0000
29.0000
Interest Expense
--
--
3,145.0000
--
--
Net Interest Income
3,945.0000
1,936.0000
-3,145.0000
10.0000
29.0000
EBIT
-85,269.0000
-88,731.0000
-58,081.0000
-40,794.0000
-28,378.0000
EBITDA
-81,444.0000
-85,894.0000
-56,188.0000
-40,112.0000
-27,930.0000
Reconciled Depreciation
3,825.0000
2,837.0000
1,893.0000
682.0000
448.0000
Net Income from Continuing Operation Net Minority Interest
-81,215.0000
-86,879.0000
-61,226.0000
-40,784.0000
-28,349.0000
Total Unusual Items Excluding Goodwill
--
-84.0000
-1,919.0000
--
--
Total Unusual Items
--
-84.0000
-1,919.0000
--
--
Normalized EBITDA
-81,444.0000
-85,810.0000
-54,269.0000
-40,112.0000
-27,930.0000
Tax Rate for Calcs
--
--
--
--
0.0001
12/31/2020 - 2/6/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VOR Vor Biopharma Inc.
1.7099
+1.78%
 
RNAC Cartesian Therapeutics, Inc.
25.57
+3.31%
 
IPSC Century Therapeutics, Inc.
3.1650
+0.48%
 
PRQR ProQR Therapeutics N.V.
1.9399
-2.27%
 
LPTX Leap Therapeutics, Inc.
2.7850
+1.27%
 
RPHM Reneo Pharmaceuticals, Inc.
1.6200
0.00%
 
NGNE Neurogene Inc.
33.04
+4.72%
 
ALXO ALX Oncology Holdings Inc.
15.40
+1.52%
 
FDMT 4D Molecular Therapeutics, Inc.
25.74
-0.04%
 
ALVR AlloVir, Inc.
0.7620
-1.31%